Researchers developed an injectable filler composed of hydroxyapatite microspheres loaded with GHK-Cu tripeptide and evaluated its anti-inflammatory and antioxidant properties in laboratory conditions. The formulation was tested using in vitro cell culture models to assess its biological activity. This is in vitro research, representing early-stage evidence that precedes animal and human clinical testing.